Frontiers in Medicinal Chemistry – Joint German-Swiss Meeting on Medicinal Chemistry: Heidelberg, Germany, March 15–18, 2009

'Frontiers in Medicinal Chemistry 2009' was organized as a joint German-Swiss meeting at the University of Heidelberg. It covered the areas of kinases and nuclear hormone receptors, inflammatory diseases, atherosclerosis and neuropsychiatry. Special sessions were dedicated to new...

Full description

Bibliographic Details
Main Authors: Werner Neidhart, Hans Peter Märki, Peter Mohr
Format: Article
Language:deu
Published: Swiss Chemical Society 2009-09-01
Series:CHIMIA
Subjects:
Online Access:https://www.chimia.ch/chimia/article/view/4711
_version_ 1819278248833449984
author Werner Neidhart
Hans Peter Märki
Peter Mohr
author_facet Werner Neidhart
Hans Peter Märki
Peter Mohr
author_sort Werner Neidhart
collection DOAJ
description 'Frontiers in Medicinal Chemistry 2009' was organized as a joint German-Swiss meeting at the University of Heidelberg. It covered the areas of kinases and nuclear hormone receptors, inflammatory diseases, atherosclerosis and neuropsychiatry. Special sessions were dedicated to new technologies in nanomedicine, proteomics and drug targeting. A session on highlights in medicinal chemistry completed the program. The lectures covered a broad range of interdisciplinary topics including molecular design and lead optimization programs, development and application of new technologies in proteomics, drug delivery & chemical synthesis.
first_indexed 2024-12-24T00:09:00Z
format Article
id doaj.art-4b5a01f307974dc9983cc58e95a86db5
institution Directory Open Access Journal
issn 0009-4293
2673-2424
language deu
last_indexed 2024-12-24T00:09:00Z
publishDate 2009-09-01
publisher Swiss Chemical Society
record_format Article
series CHIMIA
spelling doaj.art-4b5a01f307974dc9983cc58e95a86db52022-12-21T17:24:55ZdeuSwiss Chemical SocietyCHIMIA0009-42932673-24242009-09-0163910.2533/chimia.2009.573Frontiers in Medicinal Chemistry – Joint German-Swiss Meeting on Medicinal Chemistry: Heidelberg, Germany, March 15–18, 2009Werner NeidhartHans Peter MärkiPeter Mohr 'Frontiers in Medicinal Chemistry 2009' was organized as a joint German-Swiss meeting at the University of Heidelberg. It covered the areas of kinases and nuclear hormone receptors, inflammatory diseases, atherosclerosis and neuropsychiatry. Special sessions were dedicated to new technologies in nanomedicine, proteomics and drug targeting. A session on highlights in medicinal chemistry completed the program. The lectures covered a broad range of interdisciplinary topics including molecular design and lead optimization programs, development and application of new technologies in proteomics, drug delivery & chemical synthesis. https://www.chimia.ch/chimia/article/view/4711AtherosclerosisDrug targetingHighlights in medicinal chemistryInflammatory diseasesKinasesNanomedicine
spellingShingle Werner Neidhart
Hans Peter Märki
Peter Mohr
Frontiers in Medicinal Chemistry – Joint German-Swiss Meeting on Medicinal Chemistry: Heidelberg, Germany, March 15–18, 2009
CHIMIA
Atherosclerosis
Drug targeting
Highlights in medicinal chemistry
Inflammatory diseases
Kinases
Nanomedicine
title Frontiers in Medicinal Chemistry – Joint German-Swiss Meeting on Medicinal Chemistry: Heidelberg, Germany, March 15–18, 2009
title_full Frontiers in Medicinal Chemistry – Joint German-Swiss Meeting on Medicinal Chemistry: Heidelberg, Germany, March 15–18, 2009
title_fullStr Frontiers in Medicinal Chemistry – Joint German-Swiss Meeting on Medicinal Chemistry: Heidelberg, Germany, March 15–18, 2009
title_full_unstemmed Frontiers in Medicinal Chemistry – Joint German-Swiss Meeting on Medicinal Chemistry: Heidelberg, Germany, March 15–18, 2009
title_short Frontiers in Medicinal Chemistry – Joint German-Swiss Meeting on Medicinal Chemistry: Heidelberg, Germany, March 15–18, 2009
title_sort frontiers in medicinal chemistry joint german swiss meeting on medicinal chemistry heidelberg germany march 15 18 2009
topic Atherosclerosis
Drug targeting
Highlights in medicinal chemistry
Inflammatory diseases
Kinases
Nanomedicine
url https://www.chimia.ch/chimia/article/view/4711
work_keys_str_mv AT wernerneidhart frontiersinmedicinalchemistryjointgermanswissmeetingonmedicinalchemistryheidelberggermanymarch15182009
AT hanspetermarki frontiersinmedicinalchemistryjointgermanswissmeetingonmedicinalchemistryheidelberggermanymarch15182009
AT petermohr frontiersinmedicinalchemistryjointgermanswissmeetingonmedicinalchemistryheidelberggermanymarch15182009